I've received this email from the Leeds study today;
Dear Novavax Participant,
We hope this email finds you well.
Firstly, we would like to say a huge thank you for your continued support of the study; the team have been overwhelmed by your positive commitment.
We are delighted to be able to share more information about the Novavax cross-over study. The attached document is the official communication from Novavax, please do take time to read this.
There are now 2 groups of participants in the Novavax trial: those that remain blinded and those that have been unblinded after an offer of an approved COVID vaccine.
The cross-over study only applies to those that remain blinded to their treatment allocation.
For those who have been unblinded please attend your 6 month follow-up appointment as booked.
For blinded participants we plan to start the cross-over study after the Easter holiday. As soon as we have the dates confirmed we will be in touch to book appointments. The plan will be to call you back for another day 0 and day 21 visit (with a vaccination happening at each visit). This will replace your 6 month follow up visit. After this we will see you again at the original 12 month time point starting in October.
We expect this to take to take place at the Thackray Medical Museum, as with the 3 month follow-up visits.
We are looking forward to seeing you all for the next stages of the study.
With best wishes
Leeds Teaching Hospitals NHS Trust, COVID-19 Vaccine Research Delivery Team
**
This message may contain confidential information. If you are not the intended recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in relation to its contents. To do so is strictly prohibited and may be unlawful. Thank you for your co-operation.
NHSmail is the secure email and directory service available for all NHS staff in England and Scotland. NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and other accredited email services.
For more information and to find out how you can switch, portal.nhs.net/help/joiningnhsmail